The Neuroendocrine Cancer Awareness Network (NCAN) is excited to announce their new branch, NCAN NETCARE.
NCAN NETCARE is the newest addition to the NCAN family in the continuing efforts to meet the needs of the Neuroendocrine Community. NCAN NETCARE will host accredited CME and CMU programs to reach and continue education of Neuroendocrine Cancers to physicians and nurses.
After years of working towards this expansion, NCAN and NCAN NETCARE are happy to announce their first CME program coming this June in joint production with Stony Brook University, School of Medicine, Office of Continuing Medical Education (OCME) the Accredited Provider, to present Neuroendocrine Tumor Management: Evolving Therapies & Approaches on June 10th, 2017 being held at the Melville Marriott, 1350 Walt Whitman Road, Melville, NY 11747. Neuroendocrine Tumor Management: Evolving Therapies & Approaches will be a CME Catagory 1 credit worth up to 5.00. Registration for Neuroendocrine Tumor Management: Evolving Therapies & Approaches will open April 25th, 2017.
NCAN and their board has expanded on the importance of why they have decided to grow into this space:
“Over the last seven years, there has been dramatic change in the neuroendocrine (NET) field. There have been several large randomized phase III trials of novel treatments completed resulting in new drug approvals. In parallel, there has been an increased understanding of specific biological pathways implicated in neuroendocrine tumor growth. Additionally, significant developments in diagnosis, loco-regional and systemic therapy are rapidly being developed. Consequently, there is a clear need for physicians and allied health care providers to learn about the management options for patients with neuroendocrine tumors, how to sequence treatments and familiarize themselves with new therapeutic, surgical and regional approaches to these diseases.
In light of these rapid developments, we are producing these meetings to draw medical professionals who treat NET patients with the aim of disseminating new information and discussing key clinical trials goals. The intent of the conference is to provide up to date evidence based practice to health care professionals involved in the diagnosis, treatment and management of the patients living with these malignancies. Ultimately this will result in a tremendous benefit to the patient population by improved outcomes and survival.”
More CME and CMU programs will be available throughout the year! Keep an eye out and spread the word to your doctors as these important programs roll out.
NCAN has more exciting and important news to share very soon. Watch for these updates in the coming weeks!